PKM and hepatocellular carcinoma: Experimental data demonstrated decreased levels of PKM2 mediated by PB2 via an inhibition of nuclear translocation and expression of the analysed enzyme due to the disruption of an interaction between PKM/HSP90/Hif-1α in HCC cells [112].